| Affymax(R) Announces Self-Imposed Quiet Period as the Company Analyzes Phase 3 ... - MarketWatch (press release) |
|
|
MarketWatch (press release)Phase 3 clinical trials investigated the potential for Hematide to treat anemia associated with chronic renal failure. The product, upon approval, ... read more |